Allscripts (MDRX) Tops Q3 EPS by 9c

Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.27, $0.09 better than the analyst estimate of $0.18. Revenue for the quarter came in at $369.2 million versus the consensus estimate of $375.39 million.

GUIDANCE:

Allscripts sees FY2021 revenue of $1.5 billion, versus the consensus of $1.5 billion.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins